Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Intercept Pharmaceuticals (NQ: ICPT )

19.39 USD -1.36 (-6.55%)
Streaming Delayed Price Updated: 3:38 PM EST, Mar 4, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Intercept Pharmaceuticals

< Previous 1 2
...
51 52 53 54 55 56 57 58 Next >
NASDAQ Active Stock Watch List: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) and Plug Power Inc. (NASDAQ:PLUG) Added to Growing Stock Report's NASDAQ Active Stock Watch List.
New York, NY -- (SBWIRE) -- 01/09/2014 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) and Plug Power Inc. (NASDAQ:PLUG). 
From SBWire - Latest Press Releases
Morning Market Movers
Intercept Pharmaceuticals (NASDAQ: ICPT ) jumped 241.52% to $247.22 after the company reported that the FLINT trial of obeticholic acid has been stopped early and the NASH primary endpoint has been... 
Tags US8006771062 MNGA US09062X1037
From Benzinga
Intercept Pharmaceuticals (ICPT) balloon on successful tests
Intercept Pharmaceuticals (NASDAQ: ICPT) shares jumped 280% to $275.11 after the company reported that the FLINT trial of obeticholic acid has been stopped early and the NASH primary endpoint has been... 
From Baystreet.ca RSS Feed
US STOCKS-Wall Street up after claims data; Macy's jumps
* Intercept Pharma drug meets goal in trial, shares triple 
Tags companyNews
From Reuters: Company News
Higher Open Over Cautious Fed
The markets opened higher with the Dow rising 22 points to 16,485 over the Federal Reserve's cautious approach to its tapering program. Nasdaq gained 9 points to 4175. 
Tags Market News
From MarketMinute.com Market Updates
US STOCKS-Wall Street to rise after claims data; Macy's jumps
* Intercept Pharma drug meets goal in trial, shares triple 
Tags companyNews
From Reuters: Company News
BRIEF-Intercept pharma extends gains in premarket; up 206 percent
NEW YORK, Jan 9 (Reuters) - Intercept Pharmaceuticals Inc : * Pharma extends gains in premarket; up 206 percent to $221.50 after liver disease drug results 
Tags companyNews
From Reuters: Company News
BRIEF-Intercept Pharma surges 133.3 percent in premarket trade
NEW YORK, Jan 9 (Reuters) - Intercept Pharmaceuticals Inc : * Pharma surges 133.3 percent to $168.87 in premarket trade after liver disease drug meets main goal in study 
Tags companyNews
From Reuters: Company News
Benzinga's Top #PreMarket Gainers
Intercept Pharmaceuticals (NASDAQ: ICPT ) shares jumped 119.43% to $159.00 in pre-market trading after the company reported that the FLINT trial of obeticholic acid has been stopped early and the NASH... 
Tags US8173374054 BIIB Movers
From Benzinga
Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology
From GlobeNewswire News Releases
ICPT – Why Intercept Pharmaceuticals Just Exploded
 
Tags Hot Stocks NASDAQ:ICPT
From InvestorPlace
Higher Open Over Cautious Fed
Tags SGMO BIIB ALU
From MarketMinute » Market Updates
Intercept Pharmaceuticals to Provide 2013 Update on Clinical Programs for Obeticholic Acid on January 9
From GlobeNewswire News Releases
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept
Editor Note: For more information about this release, please scroll to bottom 
From PR Newswire
INTERCEPT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Intercept Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty
From PR Newswire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
From PR Newswire
Intercept Pharmaceuticals Inc Enters Oversold Territory (ICPT)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results
From PR Newswire
Hot Movers of the Day: Bank of the Ozarks (NASDAQ:OZRK) ,Celanese Co (NYSE:CE) ,Bitauto Holdings Limited (NYSE:BITA) ,Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
New York City, NY -- (SBWIRE) -- 10/28/2013 -- StockMarketIntel.com issues a special report on the following stocks: Bank of the Ozarks (NASDAQ:OZRK) ,Celanese Co (NYSE:CE) ,Bitauto Holdings Limited... 
From SBWire - Latest Press Releases
Intercept Pharmaceutical Shares Skyrocket after Oppenheimer's Data "Optimism"
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT ) have skyrocketed after Oppenheimer analyst Akiva commented on data “optimism” ahead of Phase 3 PBC data in 2Q14. Akiva noted the buying opportunity... 
Tags ICPT News Akiva
From Benzinga
Trial Results Presentations, Public Offerings, Acquisitions and Extension Study Results - Research Report on Medtronic, Steris, Intercept, Wright, and Synageva
From PR Newswire
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) and Pharmacyclics Inc. (NASDAQ:PCYC) Added to Growing Stock Report's NASDAQ Decliners Watch List.
New York, NY -- (SBWIRE) -- 10/09/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) and Pharmacyclics Inc. (NASDAQ:PCYC). 
From SBWire - Latest Press Releases
Volume Buzzers: Renren Inc (NYSE:RENN), Colonial Properties Trust Inc (NYSE:CLP), CGG (NYSE:CGG) and Intercept Pharma (NASDAQ:ICPT)
Las Vegas, NV -- (SBWIRE) -- 10/09/2013 -- PennyStockParlay.com Our process for picking penny stocks is not only unconventional, but untapped, undiscovered, and also exclusive. To keep our picks... 
From SBWire - Latest Press Releases
Intercept Prices 1.5M Share Offering at $62.50/Share
Intercept Pharmaceuticals (NASDAQ: ICPT ) announced Tuesday the pricing of an underwritten public offering of 1,500,000 shares of its common stock by certain selling stockholders at a public offering... 
Tags Benzinga Contracts Global
From Benzinga
Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders
From PR Newswire
Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors
Former Global General Manager, Senior Vice President of the Renal Franchise at Genzyme (Sanofi) Brings Key Renal Commercialization Expertise to Keryx 
From GlobeNewswire News Releases
Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA
From PR Newswire
After-hours buzz: Global Payments, Allstate & more
Check out which companies are making headlines after the bell Tuesday: 
Tags Teekay Lng Partners L/P/ Allstate Corp Economics/Consumers
From CNBC.com News
Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting
Data Support Strong Statistical Association of PBC Biochemical Endpoint with Clinical Outcomes 
From PR Newswire
UPDATE: BMO Capital Markets Raises PT on Intercept Pharmaceuticals Following 2Q13 Operating Results
In a report published Wednesday, BMO Capital Markets analyst Jim Birchenough reiterated an Outperform rating on Intercept Pharmaceuticals (NASDAQ: ICPT ), and raised the price target from $44.00 to... 
Tags BMO Capital Markets Analyst Color Price Target
From Benzinga
< Previous 1 2
...
51 52 53 54 55 56 57 58 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.